\-\ Texto\\:\\ \ \(0\)\
\-\ multiple\\ pink\\ to\\ violaceous\\ indurated\\ dermal\\ and\\ subcutaneous\\ papules\\,\\ plaques\\,\\ and\\ nodules\\ involving\\ he\\ cheeks\\,\\ temples\\,\\ and\\ upper\\ trunk\\.\\ enlarged\ \(0\)\
\-\ submental\\ and\\ right\\ posterior\\ cervical\\ lymph\\ nodes\\ are\ \(1\)\
\-\ present\\.\\ \ \(191\)\
\-\ laboratory\\:\\ cbc\\ and\\ blood\\ chemistries\\ \\-\\ normal\ \(0\)\
\-\ histopathology\\:\\ skin\\,\\ back\\:\\ malignant\\ lymphoma\\,\\ b\\-cell\\,\\ follicular\\ center\\ cell\\ origin\\.\ \(0\)\
\-\ secondary\\ cutaneous\\ b\\-cell\\ lymphoma\\,\\ follicular\\ center\\ cell\\ type\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#15b\\)\\ submitted\\ by\\:\\ mark\\ w\\.\\ cobb\\,\\ capt\\,\\ mc\\,\\ usn\ \(0\)\
\-\ patient\\ was\\ well\\ until\\ april\\,1996\\,\\ when\\ he\\ developed\\ an\\ asymptomatic\\ lesion\\ on\\ the\\ right\\ cheek\\.\\ he\\ subsequently\\ developed\\ multiple\\ lesions\\ on\\ the\\ face\\,\\ upper\\ trunk\\,\\ and\\ shoulders\\ and\\ cervical\\ adenopathy\\.\\ a\\ skin\\ biopsy\\ from\\ the\\ back\\ in\\ november\\,\\ 1996\\ was\\ diagnosed\\ as\\ malignant\\ lymphoma\\,\\ b\\-cell\\,\\ follicular\\ center\\ cell\\ origin\\.\\ further\\ work\\-up\\ at\\ nnmc\\ revealed\\:\\ \\(1\\)\\ biopsy\\ of\\ two\\ cervical\\ lymph\\ nodes\\ \\-\\ malignant\\ lymphoma\\,\\ indolent\\,\\ bcl\\-2\\ and\\ l\\-26\\ positive\\,\\ consistent\\ with\\ b\\-phenotype\\,\\ follicular\\ center\\ cell\\ origin\\;\\ \\(2\\)\\ ct\\ scans\\ of\\ chest\\,\\ abdomen\\,\\ and\\ pelvis\\ \\-\\ multiple\\ prominent\\ cervical\\ nodes\\ up\\ to\\ 1\\ cm\\,\\ multiple\\ enlarged\\ mesenteric\\ nodes\\ up\\ to\\ 1\\.5\\ cm\\,\\ splenomegaly\\,\\ and\\ malrotation\\ of\\ the\\ gut\\;\\ \\(3\\)\\ bone\\ marrow\\ biopsy\\ \\-\\ changes\\ suggestive\\ of\\ lymphoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ follicular\\:\\ 0\\.09595684414669876\ \(0\)\
\-\ center\\:\\ 0\\.07132843592650599\ \(0\)\
\-\ b\\-cell\\:\\ 0\\.06790226632978745\ \(0\)\
\-\ nodes\\:\\ 0\\.06569687432111043\ \(0\)\
\-\ cervical\\:\\ 0\\.05285261968666602\ \(0\)\
\-\ lymphoma\\:\\ 0\\.051961673072116715\ \(0\)\
\-\ origin\\:\\ 0\\.050012918604454296\ \(0\)\
\-\ trunk\\:\\ 0\\.04580026569771364\ \(0\)\
\-\ malignant\\:\\ 0\\.039429838421863414\ \(0\)\
\-\ cell\\:\\ 0\\.039289203601387\ \(0\)\
\-\ biopsy\\:\\ 0\\.03870246691451183\ \(0\)\
\-\ 15b\\:\\ 0\\.03751284435730425\ \(0\)\
\-\ capt\\:\\ 0\\.03751284435730425\ \(0\)\
\-\ april\\,1996\\:\\ 0\\.03751284435730425\ \(0\)\
\-\ l\\-26\\:\\ 0\\.03751284435730425\ \(0\)\
\-\ b\\-phenotype\\:\\ 0\\.03751284435730425\ \(0\)\
\-\ bcl\\-2\\:\\ 0\\.0345632818868364\ \(0\)\
\-\ temples\\:\\ 0\\.032837898448078245\ \(0\)\
\-\ submental\\:\\ 0\\.03161371941636854\ \(0\)\
\-\ cobb\\:\\ 0\\.03161371941636854\ \(0\)\
\-\ nnmc\\:\\ 0\\.03161371941636854\ \(0\)\
\-\ \\-\\:\\ 0\\.031178356743972145\ \(0\)\
\-\ \\,\\:\\ 0\\.031102858591347912\ \(0\)\
\-\ chemistries\\:\\ 0\\.030664172389499565\ \(0\)\
\-\ indolent\\:\\ 0\\.030664172389499565\ \(0\)\
\-\ multiple\\:\\ 0\\.03063499580390245\ \(0\)\
\-\ he\\:\\ 0\\.030436434153613013\ \(0\)\
\-\ lymph\\:\\ 0\\.029357807735699123\ \(0\)\
\-\ mark\\:\\ 0\\.02866415694590069\ \(0\)\
\-\ usn\\:\\ 0\\.02866415694590069\ \(0\)\
\-\ violaceous\\:\\ 0\\.02816295253885225\ \(0\)\
\-\ cheeks\\:\\ 0\\.02816295253885225\ \(0\)\
\-\ developed\\:\\ 0\\.02800055731774225\ \(0\)\
\-\ skin\\:\\ 0\\.027933012214799813\ \(0\)\
\-\ indurated\\:\\ 0\\.026938773507142542\ \(0\)\
\-\ gut\\:\\ 0\\.026938773507142542\ \(0\)\
\-\ november\\:\\ 0\\.02571459447543284\ \(0\)\
\-\ w\\.\\:\\ 0\\.02545661736132035\ \(0\)\
\-\ enlarged\\:\\ 0\\.024813796343693673\ \(0\)\
\-\ cheek\\:\\ 0\\.02476504744856386\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.02476504744856386\ \(0\)\
\-\ dermal\\:\\ 0\\.024359472215353967\ \(0\)\
\-\ pink\\:\\ 0\\.024170315778882335\ \(0\)\
\-\ \\:\\:\\ 0\\.024048400340226914\ \(0\)\
\-\ back\\:\\ 0\\.02399205391785087\ \(0\)\
\-\ papules\\:\\ 0\\.02364860376997879\ \(0\)\
\-\ 1996\\:\\ 0\\.022765032004964984\ \(0\)\
\-\ shoulders\\:\\ 0\\.022033754315915373\ \(0\)\
\-\ submitted\\:\\ 0\\.02150773748201249\ \(0\)\
\-\ mc\\:\\ 0\\.02131428057104757\ \(0\)\
\-\ cutaneous\\:\\ 0\\.021129237541516768\ \(0\)\
\-\ work\\-up\\:\\ 0\\.0205384441591584\ \(0\)\
\-\ 1997\\:\\ 0\\.02038368822651638\ \(0\)\
\-\ malrotation\\:\\ 0\\.02038368822651638\ \(0\)\
\-\ plaques\\:\\ 0\\.020308370877157225\ \(0\)\
\-\ histopathology\\:\\ 0\\.020308370877157225\ \(0\)\
\-\ seminar\\:\\ 0\\.02023436346136204\ \(0\)\
\-\ uniformed\\:\\ 0\\.020019764084226326\ \(0\)\
\-\ services\\:\\ 0\\.019620535338619287\ \(0\)\
\-\ dermatology\\:\\ 0\\.019620535338619287\ \(0\)\
\-\ up\\:\\ 0\\.01955614596641892\ \(0\)\
\-\ cm\\:\\ 0\\.01950600951333605\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.018919449240423308\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.018179675071048913\ \(0\)\
\-\ face\\:\\ 0\\.017832108981626498\ \(0\)\
\-\ upper\\:\\ 0\\.017549621322286966\ \(0\)\
\-\ 1\\:\\ 0\\.01730490525923155\ \(0\)\
\-\ \\;\\:\\ 0\\.017237627135766754\ \(0\)\
\-\ scans\\:\\ 0\\.016932921349000086\ \(0\)\
\-\ mesenteric\\:\\ 0\\.01676732383304403\ \(0\)\
\-\ subsequently\\:\\ 0\\.01648457872917955\ \(0\)\
\-\ cbc\\:\\ 0\\.01624811127745695\ \(0\)\
\-\ adenopathy\\:\\ 0\\.016190992042001032\ \(0\)\
\-\ marrow\\:\\ 0\\.015996904760077407\ \(0\)\
\-\ until\\:\\ 0\\.015969886769955453\ \(0\)\
\-\ suggestive\\:\\ 0\\.015535031702310572\ \(0\)\
\-\ nodules\\:\\ 0\\.015074548363415964\ \(0\)\
\-\ prominent\\:\\ 0\\.014924471176873589\ \(0\)\
\-\ \\#\\:\\ 0\\.01426249625081229\ \(0\)\
\-\ laboratory\\:\\ 0\\.013400390365336452\ \(0\)\
\-\ diagnosed\\:\\ 0\\.013371043220404279\ \(0\)\
\-\ pelvis\\:\\ 0\\.013213154921666505\ \(0\)\
\-\ involving\\:\\ 0\\.012759179846822526\ \(0\)\
\-\ \\(\\:\\ 0\\.01229551874457635\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.012291882544664201\ \(0\)\
\-\ type\\:\\ 0\\.012257975439774086\ \(0\)\
\-\ \\)\\:\\ 0\\.012145322418949875\ \(0\)\
\-\ positive\\:\\ 0\\.011799513150145179\ \(0\)\
\-\ revealed\\:\\ 0\\.011670101659004652\ \(0\)\
\-\ further\\:\\ 0\\.011563592092767055\ \(0\)\
\-\ abdomen\\:\\ 0\\.010771847927215729\ \(0\)\
\-\ changes\\:\\ 0\\.010421480749936428\ \(0\)\
\-\ when\\:\\ 0\\.010414175479217046\ \(0\)\
\-\ two\\:\\ 0\\.010414175479217046\ \(0\)\
\-\ secondary\\:\\ 0\\.010166084963867266\ \(0\)\
\-\ blood\\:\\ 0\\.009925153500039573\ \(0\)\
\-\ lesions\\:\\ 0\\.009734300026995522\ \(0\)\
\-\ bone\\:\\ 0\\.009035892261531361\ \(0\)\
\-\ consistent\\:\\ 0\\.008916162846090226\ \(0\)\
\-\ chest\\:\\ 0\\.008700974468329866\ \(0\)\
\-\ 3\\:\\ 0\\.008514789475346977\ \(0\)\
\-\ was\\:\\ 0\\.008410872529478185\ \(0\)\
\-\ posterior\\:\\ 0\\.008381440632776377\ \(0\)\
\-\ well\\:\\ 0\\.008225876395611282\ \(0\)\
\-\ present\\:\\ 0\\.008212803208219918\ \(0\)\
\-\ case\\:\\ 0\\.007955338012201153\ \(0\)\
\-\ 2\\:\\ 0\\.007830231900044877\ \(0\)\
\-\ right\\:\\ 0\\.007673461354131206\ \(0\)\
\-\ and\\:\\ 0\\.0076599576907326996\ \(0\)\
\-\ lesion\\:\\ 0\\.0074066179829806586\ \(0\)\
\-\ on\\:\\ 0\\.006160774573322792\ \(0\)\
\-\ by\\:\\ 0\\.006054769801042021\ \(0\)\
\-\ normal\\:\\ 0\\.005700478530208941\ \(0\)\
\-\ as\\:\\ 0\\.005500329812315437\ \(0\)\
\-\ to\\:\\ 0\\.005451933299272165\ \(0\)\
\-\ from\\:\\ 0\\.005389088141081755\ \(0\)\
\-\ ct\\:\\ 0\\.0050863985250725234\ \(0\)\
\-\ an\\:\\ 0\\.005028361124615872\ \(0\)\
\-\ are\\:\\ 0\\.004956910095870646\ \(0\)\
\-\ at\\:\\ 0\\.004926651714177162\ \(0\)\
\-\ patient\\:\\ 0\\.003645072046452715\ \(0\)\
\-\ the\\:\\ 0\\.002353179314104269\ \(0\)\
\-\ of\\:\\ 0\\.001983043417838101\ \(0\)\
\-\ in\\:\\ 0\\.001793179702724489\ \(0\)\
\-\ a\\:\\ 0\\.0016876587311429841\ \(0\)\
\-\ \\.\\:\\ 0\\.0010574329901337188\ \(0\)\
\-\ with\\:\\ 0\\.0004978901110208074\ \(0\)\
